Skip to main content
. 2017 Mar 25;45(5):380–388. doi: 10.1159/000464476

Fig. 2.

Fig. 2

Observed mean hemoglobin (Hb) concentration over the trial period during administration of vadadustat or placebo (modified intent to treat population). Data are expressed as the mean ± SEM Hb value at each time point. * p < 0.05 for comparisons with baseline. † p < 0.05 for comparisons with placebo.